Get email updates from SABCSMeetingNews.org
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.
DECEMBER 6–10, 2022
Henry B. Gonzalez Convention Center
|
San Antonio, TX
-
Osborne Symposium highlights growing understanding of HER2, ER crosstalk
C. Kent Osborne, MD, opened a session named in his honor on Wednesday as experts discussed the interplay between estrogen receptors and HER2 signaling pathways.
-
McGuire Lecturer, Jeffrey Rosen, PhD, reviews work with preclinical models in breast cancer research
Jeffrey Rosen, PhD, a pioneer of mouse modeling and mouse mammary tumorigenesis, received the William L. McGuire Memorial Lecture Award.
-
Debate to weigh differences, similarities of CDK4/6 inhibitors
Ruth O’Regan, MD, and Debra Patt, MD, PhD, MBA, will take sides on the impacts of CDK4/6 inhibitors during a Thursday morning debate session.
-
Panel to discuss evolving role of liquid biopsies in breast cancer treatment and research
Nicholas Turner, MD, PhD, will moderate a Thursday afternoon session that will provide an update on the current uses of liquid biopsies in metastatic disease as well as growing applications for ctDNA in clinical trials.
-
Management of Hereditary Risk: Moderate-Risk Genes and New Approaches: Presenter Profiles
Madeleine M.A. Tilanus-Linthorst, MD, PhD, and Joanne Kotsopoulos, MSc, PhD, preview their Thursday afternoon presentations.
-
What ctDNA Can Tell Us: Presenter Profile
Minetta C. Liu, MD, previews a Thursday afternoon presentation on using ctDNA in detecting disease.
-
New Translational Controversies session to feature ‘lightning discussions’ on important topics
Komal Jhaveri, MD, FACP, will moderate discussions about current controversies in translational medicine for breast cancer.
-
Panel to discuss approaches to managing moderate hereditary risk for breast cancer
Seema A. Khan, MD, will lead a session on Thursday afternoon looking at evolving evidence on managing patients at moderate genetic breast cancer risk.
-
Session will explore diagnostic and treatment challenges of less common breast cancer types
An educational session on Thursday, moderated by Bora Lim, MD, will explore the diagnosis and treatment of less common, more challenging, breast cancers.
-
Demystifying CDKs in Breast Cancer: Beyond CDK4/6: Presenter Profiles
Ariella Hanker, PhD, and Sarat Chandarlapaty, MD, PhD, preview their presentations on inhibitors, set for Thursday afternoon.